|
|
 |
 |
|
|
|
|
 |
|
|
|
|
|
|
|
表 題 |
著者名 |
誌
名 |
Oncology |
| Peroxisome proliferator-activated receptor γ coactivator-1α interacts with the androgen receptor (AR) and promotes prostate cancer cell growth by activating the AR. |
Shiota M, Yokomizo A, Tada Y, Inokuchi J, Tatsugami K, Kuroiwa K, Uchiumi T, Fujimoto N, Seki N, Naito S: |
Mol Endocrinol 24 (1): 114-127, 2010 |
| N-myc downstream regulated gene-1/Cap43 may play an important role in malignant progression of prostate cancer, in its close association with E-cadherin. |
Song YH, Oda Y, Hori M, Kuroiwa K, Ono M, Hosoi F, Basaki Y, Tokunaga S, Kuwano M, Naito S, Tsuneyoshi M: |
Hum Pathol 41 (2): 214-222, 2010 |
| Human heterochromatin protein 1 isoform HP1β enhances androgen receptor activity and is implicated in prostate cancer growth. |
Shiota M, Song Y, Yokomizo A, Tada Y, Kuroiwa K, Eto M, Oda Y, Inokuchi J, Uchiumi T, Fujimoto N, Seki N, Naito S: |
Endocr Relat Cancer 17 (2): 455-467, 2010 |
| Sorafenib with doxorubicin augments cytotoxicity to renal cell cancer through PERK inhibition. |
Shiota M, Eto M, Yokomizo A, Tada Y, Takeuchi A, Masubuchi D, Inokuchi J, Tatsugami K, Kuroiwa K, Uchiumi T, Seki N, Naito S: |
Int J Oncol 36 (6): 1521-1532, 2010 |
| Polymorphisms in estrogen related genes may modify the protective effect of isoflavones against prostate cancer risk in Japanese men. |
Sonoda T, Suzuki H, Mori M, Tsukamoto T, Yokomizo A, Naito S, Fujimoto K, Hirao Y, Miyanaga N, Akaza H: |
Eur J Cancer Prev 19 (2): 131-137, 2010 |
| Castration resistance of prostate cancer cells caused by castration-induced oxidative stress through Twist1 and androgen receptor overexpression. |
Shiota M, Yokomizo A, Tada Y, Inokuchi J, Kashiwagi E, Masubuchi D, Eto M, Uchiumi T, Naito S: |
Oncogene 29 (2): 237-250, 2010 |
| Prognosis of Japanese metastatic renal cell carcinoma patients in the cytokine era: a cooperative group report of 1463 patients. |
Naito S, Yamamoto N, Takayama T, Muramoto M, Shinohara N, Nishiyama K, Takahashi S, Maruyama R, Saika T, Hoshi S, Nagao K, Yamamoto S, Sugimura I, Uemura H, Koga S, Takahashi M, Ito F, Ozono S, Terachi T, Naito S, Tomita Y: |
Eur Urol 57 (2): 317-326, 2010 |
| A phase II study of Sunitinib in Japanese patients with metastatic renal cell carcinoma: insights into the treatment, efficary and safety. |
Uemura H, Shinohara N, Yuasa T, Tomita Y, Fujimoto H, Niwakawa M, Mugiya S, Miki T, Nonomura N, Takahashi M, Hasegawa Y, Agata N, Houk B, Naito S, Akaza H: |
Jpn J Clin Oncol 40 (3): 194-202, 2010 |
| Tip60 promotes prostate cancer cell proliferation by translocation of androgen receptor into the nucleus. |
Shiota M, Yokomizo A, Masubuchi D, Tada Y, Inokuchi J, Eto M, Uchiumi T, Fujimoto N, Naito S: |
Prostate 70 (5): 540-554, 2010 |
| Influence of immunotherapy with interferon-alpha on regulatory T cells in renal cell carcinoma patients. |
Tatsugami K, Eto M, Naito S: |
J Interferon Cytokine Res 30 (1): 43-48, 2010 |
| Enhanced antitumor effects of an engineered measles virus edmonston strain expressing the wild-type N, P, L genes on human renal cell carcinoma. |
Meng X, Nakamura T, Okazaki T, Inoue H, Takahashi A, Miyamoto S, Sakaguchi G, Eto M, Naito S, Takeda M, Yanagi Y, Tani K: |
Mol Ther 18 (3): 544-551, 2010 |
| Osteoblast-specific factor 2 expression in prostate cancer-associated stroma: identification through microarray technology. |
Furusato B, Tsunoda T, S Shaheduzzaman, ME Nau, M Vahey, G Petrovics, DG McLeod, Naito S, Shirasawa S, S Srivastava, IA Sesterhenn: |
Urology 75 (4): 768-772, 2010 |
| Skeletal-related events in urological cancer patients with bone metastasis: a multicenter study in Japan. |
Yokomizo A, Koga H, Shinohara N, Miyahara T, Machida N, Tsukino H, Uozumi J, Nishiyama K, Satoh F, Sakai H, Naito S: |
Int J Urol 17 (4): 332-336, 2010 |
| Discrepancy between local and central pathological review of radical prostatectomy specimens. |
Kuroiwa K, Shiraishi T, Ogawa O, Usami M, Hirao Y, Seiji N, for the Clinicopathological Research Group for Localized Prostate Cancer Investigators: |
J Urol 183 (3): 952-957, 2010 |
| Foxo3a expression and acetylation regulate cancer cell growth and sensitivity to cisplatin. |
Shiota M, Yokomizo A, Kashiwagi E, Tada Y, Inokuchi J, Tatsugami K, Kuroiwa K, Uchiumi T, Seki N, Naito S: |
Cancer Sci 101 (5): 1177-1185, 2010 |
| Successful outcomes using combination therapy of interleukin-2 and interferon-α for renal cell carcinoma patients with lung metastasis. |
Akaza H, Kawai K, Tsukamoto T, Fujioka T, Tomita Y, Kitamura T, Ozono S, Miki T, Naito S, Zembutsu H, Nakamura Y: |
Jpn J Clin Oncol 40 (7): 684-689, 2010 |
| P300/CBP-associated factor regulates Y-box binding protein-1 expression and promotes cancer cell growth, cancer invasion and drug resistance. |
Shiota M, Yokomizo A, Tada Y, Uchiumi T, Inokuchi J, Tatsugami K, Kuroiwa K, Yamamoto K, Seki N, Naito S: |
Cancer Sci 101 (8): 1797-1806, 2010 |
| Sensitivity of doxorubicin-resistant cells to sorafenib: possible role for inhibition of eukaryotic initiation factor-2alpha phosphorylation. |
Shiota M, Eto M, Yokomizo A, Tada Y, Takeuchi A, Itsumi M, Tatsugami K, Uchiumi T, Naito S: |
Int J Oncol 37 (2): 509-517, 2010 |
| Maintenance intravesical bacillus Calmette-Guerin instillation for Ta,T1 cancer amd carcinoma in situ of the bladder: Randomized controlled trial by the BCG Tokyo Strain Study Group. |
Koga H, Ozono S, Tsushima T, Tomita K, Horiguchi Y, Usami M, Hirao Y, Akaza H, Naito S, BCG Tokyo Strain Study Group: |
Int J Urol 17 (9): 759-767, 2010 |
| Efficacy of S-1 in patients with castration-resistant prostate cancer: a phase II study. |
Akaza H, Ikemoto I, Namiki M, Usami M, Kobayashi M, Fujimoto H, Tsukamoto T, Naito S: |
Oncology 78 (5-6): 323-328, 2010 |
| Histopathologic subtype-specific genomic profiles of renal cell carcinomas identified by high-resolution whole-genome single nucleotide polymorphism array analysis. |
Yokomizo A, Yamamoto K, Furuno K, Shiota M, Tatsugami K, Kuroiwa K, Naito S: |
Oncol Lett 1 (6): 1073-1078, 2010 |
| Identification of a set of genes associated with response to interleukin-2 and interferon-α combination therapy for renal cell carcinoma through genome-wide gene expression profiling. |
Mizumori O, Zembutsu H, Kato Y, Tsunoda T, Miya F, Morizono T, Tsukamoto T, Fujioka T, Tomita Y, Kitamura T, Ozono S, Miki T, Naito S, Akaza H, Nakamura Y: |
Exp Ther Med 1 (6): 955-961, 2010 |
| An early phase II trial of S-1 in Japanese patients with cytokine-refractory metastatic renal cell carcinoma. |
Naito S, Tsukamoto T, Usami M, Fujimoto H, Akaza H: |
Cancer Chemother Pharmacol 66 (6): 1065-1070, 2010 |
| Mechanism of synergistic antitumor effect of Sorafenib and Interferon-α treatment of renal cell carcinoma. |
Takeuchi A, Eto M, Tatsugami K, Yamada H, Oki T, Kiyoshima K, Yoshikai Y, Naito S: |
J Urol 184 (6): 2549-2556, 2010 |
| Multicenter phase II trial of S-1 in patients with cytokine-refractory metastatic renal cell carcinoma. |
Naito S, Eto M, Shinohara N, Tomita Y, Fujisawa M, Namiki M, Nishikido M, Usamu M, Tsukamoto T, Akaza H: |
Clin Oncol 28 (34): 5022-5029, 2010 |
| Overall survival and updated results from a Phase II study of Sunitinib in Japanese patients with metastatic renal cell carcinoma. |
Tomita Y, Shinohara N, Yuasa T, FujimotoH, Niwakawa M, Mugiya S, Miki T, Uemura H, Nonomura N, Takahashi M, Hasegawa Y, Agata N, Houk B, Naito S, Akaza H: |
Jpn J Clin Oncol 40 (12): 1166-1172, 2010 |
| Foxo3a suppression of urothelial cancer invasiveness through Twist1, Y-box-binding protein 1, and E-cadherin regulation. |
Shiota M, Song Y, Yokomizo A, Kiyoshima K, Tada Y, Uchino H, Uchiumi T, Inokuchi J, Oda Y, Kuroiwa K, Tatsugami K, Naito S: |
Clin Cancer Res 16 (23): 5654-5663, 2010 |
| Histone acetyltransferase inhibitory activity of bokbunja (Rubus coreanus Miq.) ethanol extrct on androgen receptor-dependent prostate cancer cell growth. |
Kim MJ, Seong AR, Lee YH, Kim YJ, Shiota M, Yokomizo A, Naito S, Lee J, Jun W, Yoon HG: |
Food Sci Biotechnol 19 (6): 1503-1511, 2010 |
Endourology |
| Transurethral endoscopic treatment of patients with upper tract urothelial carcinomas using neodymium-YAG and/or holmium-YAG laser ablation. |
Tada Y, Yokomizo A, Koga H, Seki N, Kuroiwa K, Tatsugami K, Yamaguchi A, Naito S: |
BJU Int 106 (3): 362-366, 2010 |
| Evaluation of narrow-band imaging as a complementary method for the detection of bladder cancer. |
Tatsugami K, Kuroiwa K, Kamoto T, Nishiyama H, Watanabe J, Ishikawa S, Shinohara N, Sazawa A, Fukushima S, Naito S: |
J Endourol 24 (11): 1807-1811, 2010 |
Meeting Report |
| Fifth joint meeting of the American Urological Association and the Japanese Urological Association international affiliate society meeting at the 105the annual meeting of the American Urological Association. |
Myers RP, Seki N, Gotoh M, Chai TC, Kaplan SA, Inoue K, Trachtenberg J, Kikuchi E, Nishiyama H, Chang SS, Lee C, Muto S, Ito S, Andriole GL, Eto M, Sumitomo M, Kamba T, Wood CG, Margulis V, Naito S, Egawa S: |
Int J Urol 17 (8): 743-752, 2010 |
和文 |
| 福岡市前立腺がん検診における精密検査の実施に関する実態調査. |
古賀寛史、宮崎良春、内藤誠二、山口秋人： |
日本がん検診・診断学会誌 17 (3): 246-250, 2010 |
| 前立腺間質、正常上皮および癌間質間のネットワーク構成の比較−前立腺癌フィールドエフェクトの解析−. |
石井健一朗、角田俊之、内藤誠二、杉村芳樹： |
泌尿外 23 (8): 1025-1027, 2010 |
| 前立腺癌のアンドロゲン除去下の酸化ストレスによる内分泌療法不応性獲得. |
塩田真己、横溝 晃、多田靖弘、猪口淳一、内藤誠二： |
泌尿外 23 (8): 1023-1024, 2010 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
